Last update 31 May 2024

Mim8

Overview

Basic Info

Drug Type
Bispecific antibody
Synonyms
Coagulation factor VIII mimetic antibody, FVIII mimetic antibody, MIM 8
+ [2]
Mechanism
F10 inhibitors(Coagulation factor X inhibitors), factor IXa inhibitors(Factor IXa inhibitors)
Active Indication
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hemophilia APhase 3
US
02 Dec 2021
Hemophilia APhase 3
CN
02 Dec 2021
Hemophilia APhase 3
JP
02 Dec 2021
Hemophilia APhase 3
AT
02 Dec 2021
Hemophilia APhase 3
BE
02 Dec 2021
Hemophilia APhase 3
CA
02 Dec 2021
Hemophilia APhase 3
CZ
02 Dec 2021
Hemophilia APhase 3
DK
02 Dec 2021
Hemophilia APhase 3
FR
02 Dec 2021
Hemophilia APhase 3
DE
02 Dec 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
254
Mim8 once-weekly
iwbzmwfbst(gcppydtwbh) = mxhbfjxjsu dteygnnhkt (ycmxbefjpm )
Met
Positive
13 May 2024
Mim8 once-monthly
iwbzmwfbst(gcppydtwbh) = pzfcknberz dteygnnhkt (ycmxbefjpm )
Met
Not Applicable
-
idfwntvlpf(bzathwaszs) = neqndrzkrk tsugoushey (zhhbvzyhfk )
-
10 Dec 2023
Phase 1/2
42
zwrimfrbje(mzztxnoxjo) = bagxelrmbu srcqansyae (cghogqshsw )
Positive
15 Nov 2022
Phase 1/2
-
-
(SAD phase)
ogvtsqjyhl(myselppcus) = Mim8 was well tolerated following both single and multiple dosing, and no thromboembolic events or related serious adverse events were reported zjpkjyxtfp (anxvjdehtc )
Positive
11 Jul 2022
(MAD phase)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free